REFERENCES
1. Kaskie RE, Ferrarelli F. Investigating the neurobiology of schizophrenia and other major psychiatric disorders with transcranial magnetic stimulation. Schizophr Res 2017; doi: 10.1016/j.schres.2017.04.045.
2. Dougall N, Maayan N, Soares-Weiser K, McDermott LM, McIntosh A. Transcranial magnetic stimulation for schizophrenia. Schizophr Bull 2015;41:1220-22.
3. van den Noort M, Lim S, Litscher G, Bosch P. Transcranial magnetic stimulation for treating older patients with treatment-resistant depression. J Affect Disord 2017;225:278-9.
4. Davis NJ. Transcranial stimulation of the developing brain: a plea for extreme caution. Front Hum Neurosci 2014;8:600.
5. Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009;120:2008-39.
6. Arnedo J, Svrakic DM, Del Val C, Romero-Zaliz R, Hernández-Cuervo H, Molecular Genetics of Schizophrenia Consortium, Fanous AH, Pato MT, Pato CN, de Erausquin GA, Cloninger CR, Zwir I. Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies. Am J Psychiatry 2015;172:139-53.
